ロード中...
Prevalence of human parvovirus B19 in Chinese plasma pools for manufacturing plasma derivatives
BACKGROUND: Human parvovirus B19 (B19V) is a frequent contaminant of blood and plasma-derived medicinal products. To ensure the quality and safety of plasma-derived products, European regulations, Plasma Protein Therapeutics Association (PPTA) standard and FDA guidelines require testing of manufactu...
保存先:
| 出版年: | Virol J |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4596515/ https://ncbi.nlm.nih.gov/pubmed/26445095 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12985-015-0396-z |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|